应对心房颤动合并冠状动脉疾病患者抗栓治疗的复杂局面：来自AUGUSTUS研究的经验教训 - Suppr

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

作者信息

Harskamp Ralf E, Alexander John H, Lopes Renato D

机构信息

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Amsterdam UMC, University of Amsterdam, Department of General Practice, Amsterdam Cardiovascular Sciences Research Institute, The Netherlands.

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

出版信息

Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.

DOI:10.1016/j.ejim.2019.05.018

PMID:31128977

Abstract

摘要

相似文献

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.

Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.

And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?

Eur J Intern Med. 2019 Jul;65:1-3. doi: 10.1016/j.ejim.2019.05.019. Epub 2019 May 23.

Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Cardiol Clin. 2020 Nov;38(4):551-561. doi: 10.1016/j.ccl.2020.07.006. Epub 2020 Sep 17.

Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.

Clin Ther. 2014 Sep 1;36(9):1176-81. doi: 10.1016/j.clinthera.2014.08.010.

Antithrombotics in atrial fibrillation and coronary disease.

Expert Rev Cardiovasc Ther. 2014 Aug;12(8):977-86. doi: 10.1586/14779072.2014.937427.

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.

Circulation. 2019 Dec 3;140(23):1921-1932. doi: 10.1161/CIRCULATIONAHA.119.043308. Epub 2019 Sep 26.

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.

Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004395.

Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.

Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.

[Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].

Ann Cardiol Angeiol (Paris). 2018 Dec;67(6):404-410. doi: 10.1016/j.ancard.2018.09.013. Epub 2018 Oct 17.

引用本文的文献

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.

JAMA Cardiol. 2020 May 1;5(5):582-589. doi: 10.1001/jamacardio.2019.6175.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

作者信息

Harskamp Ralf E, Alexander John H, Lopes Renato D

机构信息

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

出版信息

Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.

DOI:10.1016/j.ejim.2019.05.018

PMID:31128977

Abstract

摘要

相似文献

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.

Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.

And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?

Eur J Intern Med. 2019 Jul;65:1-3. doi: 10.1016/j.ejim.2019.05.019. Epub 2019 May 23.

Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Cardiol Clin. 2020 Nov;38(4):551-561. doi: 10.1016/j.ccl.2020.07.006. Epub 2020 Sep 17.

Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.

Clin Ther. 2014 Sep 1;36(9):1176-81. doi: 10.1016/j.clinthera.2014.08.010.

Antithrombotics in atrial fibrillation and coronary disease.

Expert Rev Cardiovasc Ther. 2014 Aug;12(8):977-86. doi: 10.1586/14779072.2014.937427.

Circulation. 2019 Dec 3;140(23):1921-1932. doi: 10.1161/CIRCULATIONAHA.119.043308. Epub 2019 Sep 26.

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.

Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004395.

Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.

Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.

[Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].

Ann Cardiol Angeiol (Paris). 2018 Dec;67(6):404-410. doi: 10.1016/j.ancard.2018.09.013. Epub 2018 Oct 17.

引用本文的文献

Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.

JAMA Cardiol. 2020 May 1;5(5):582-589. doi: 10.1001/jamacardio.2019.6175.

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

作者信息

机构信息

出版信息

相似文献

引用本文的文献